There exists a need for an animal model that would replicate some of the characteristics of the oral dyskinesias that occur in tardive dyskinesia, a long-lived motor abnormality that arises after excessive use of neuroleptic agents in humans. This model would be useful to investigate mechanisms that may be involved in tardive dyskinesia, and to test agents that have a potential to prevent or even reverse the motor or biochemical abnormalities that occur in tardive dyskinesia. Testing equipment is available for measuring the frequency of mouth openings, the amplitude of mouth movement, and the rates of mouth opening and closing. The technology uses frame grabbers to record the relative positions of upper to lower jaws at increments of 1/60 sec. With a computer assist, the data are recorded as amplitude of mouth opening vs. time. Fast fourier transformation provides an energy spectrum of the oral activity, so that comparison can be made with the low frequency mouth movements of tardive dyskinesia. The project is designed to set up this equipment in the laboratory to determine the oral characteristics of rats that have abnormal oral activity. We have found that there is a 10 fold increase in dopamine D2 antagonist-induced oral activity in adult rats that received a neonatal 6-hydroxydopamine lesion of the dopaminergic fibers in the brain. A similar enhancement of oral activity was produced by a Dl agonist in these rats. In this project we shall determine how the features of the oral activity in these and related models, compare with that shown for tardive dyskinesia. The Bmax and Kd for Dl and D2 receptors in the striatum will be determined, as well as the ratio of high and low affinity forms of each receptor type. Biochemical determination of the status of the receptor complex will be made for potentially useful models. The final study will explore the possible effects of a peptide that modulates the dopamine receptor, and which could possibly be useful in treatment of tardive dyskinesia. A new model to investigate aspects of tardive dyskinesia would be of immense value. The proposed model is of added benefit since the susceptibility for induction of oral activity is seemingly permanent.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15NS029505-01
Application #
2267669
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1991-06-01
Project End
1995-05-31
Budget Start
1991-06-01
Budget End
1995-05-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
East Tennessee State University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Johnson City
State
TN
Country
United States
Zip Code
37614
Kostrzewa, Richard M; Kostrzewa, Florence P (2012) Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny. Neurotox Res 21:231-5
Kostrzewa, Richard M; Huang, Nuo-Yu; Kostrzewa, John P et al. (2007) Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res 11:41-50
Kostrzewa, R M; Brus, R; Perry, K W (1999) Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system. Pol J Pharmacol 51:39-47
Huang, N Y; Kostrzewa, R M; Li, C et al. (1997) Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. J Pharmacol Exp Ther 280:268-76
Kostrzewa, R M; Brus, R; Perry, K W et al. (1996) Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content. Acta Neurobiol Exp (Wars) 56:21-8
Kostrzewa, R M (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19:1-17
Plech, A; Brus, R; Kalbfleisch, J H et al. (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology (Berl) 119:466-73
Brus, R; Plech, A; Kostrzewa, R M (1995) Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine. Pharmacol Biochem Behav 50:649-53
Huang, N Y; Kostrzewa, R M (1994) Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 271:433-7
Gong, L; Kostrzewa, R M; Li, C (1994) Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J Neurochem 63:1282-90

Showing the most recent 10 out of 22 publications